Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
May 29, 2026, 17:20

Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care

Martin Widschwendter, Director of The Daffodil Centre and European Translational Oncology Prevention and Screening Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in International Journal of Gynecological Cancer, adding:

“Thrilled to share that our perspective article is now published in the International Journal of Gynecological Cancer!

The paper examines the current clinical pathway for detection of endometrial cancer — and makes the case for how novel molecular detection tests could fundamentally transform how we triage women presenting with abnormal uterine or postmenopausal bleeding.

Transforming Endometrial Cancer Diagnosis: The Case for Molecular Triage in Abnormal Uterine and Postmenopausal Bleeding

This was a wonderful collaboration with a truly outstanding multi-national group of clinicians, scientists, and public health policy experts — a huge thank you to all co-authors.”

Title: Transforming Endometrial Cancer Diagnosis: The Case for Molecular Triage in Abnormal Uterine and Postmenopausal Bleeding

Authors: Adeola Olaitan, Nora Pashayan, John Butler, David Cibula, Laura Costas, Emma J. Crosbie, Henrik Falconer, Christina Fotopoulou, Patrick Kafui Akapo, Nicola MacDonald, Esther Moss, Michael Mueller, Adam N. Rosenthal, Karin Sundström, Peter Hillemanns, Ranjit Manchanda, Sara Sleigh, Martin Widschwendter

Martin Widschwendter

Stay updated on all scientific advances with Hemostasis Today.